InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Ray Nitya G., Chief Technology Officer. Director active across 1 company, notably CytoDyn Inc.. Cumulatively, 14 disclosures have been logged. Activity tracked since 6 August 2021. The latest transaction was disclosed on 15 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
13,671 shares0Common StockSEC:0001104659-22-119978:0
16,084 shares0Common StockSEC:0001104659-22-114098:0
12,428 shares0Common StockSEC:0001104659-22-109693:0
13,020 shares0Common StockSEC:0001104659-22-105983:0
8,965 shares0Common StockSEC:0001104659-22-101254:0
10,516 shares0Common StockSEC:0001104659-22-097602:0
6,588 shares0Common StockSEC:0001104659-22-092175:0
7,102 shares0Common StockSEC:0001104659-22-086132:0
12,428 shares0Common StockSEC:0001104659-22-080838:0
13,020 shares0Common StockSEC:0001104659-22-077436:0
13,671 shares0Common StockSEC:0001104659-22-073013:0
14,780 shares0Common StockSEC:0001104659-22-069303:0
34,801 shares0Common stockSEC:0000899243-21-032389:0
34,801 shares0Common stockSEC:0000899243-21-032389
14 of 14 declarations
About Ray Nitya G.
Ray Nitya G. serves as Chief Technology Officer at CytoDyn Inc. She is responsible for the company's technology strategy and innovation. Her role is essential for supporting the development of new products and technologies.
